Table 2. Meta-analysis of associations between MTHFR C677T, A1298C polymorphisms and OSCC risk using the additive, dominant, recessive model.
SNP | Comparison | OR with 95%CI | Heterogeneity | Publication Bias | |||
---|---|---|---|---|---|---|---|
χ2 | Q test | I2 | Begg | Egger | |||
C677T | |||||||
Overall | T vs C | 1.35 (1.04–2.24) | 41.4 | <0.01 | 73.4% | 0.83 | 0.34 |
TT vs CT | 1.14 (0.82–1.58) | 10.6 | 0.48 | 0.00% | 0.63 | 0.94 | |
TT vs CC | 1.79 (1.28–2.50) | 16.5 | 0.123 | 33.5% | 0.73 | 0.98 | |
CT vs CC | 1.45 (1.02–2.08) | 40.2 | <0.01 | 72.1% | 0.78 | 0.93 | |
TT vs CT+CC | 1.40 (0.73–2.48) | 37.1 | <0.01 | 17.3% | 0.58 | 0.53 | |
CT+TT vs CC | 1.43 (1.02–1.99) | 37.3 | <0.01 | 70.5% | 0.83 | 0.44 | |
Asian | T vs C | 1.59 (0.91–2.78) | 21.6 | <0.01 | 81.0% | 0.62 | 0.52 |
TT vs CT | 1.55 (0.87–2.78) | 0.91 | 0.92 | 0.00% | 1.00 | 0.83 | |
TT vs CC | 2.65 (1.51–4.64) | 0.75 | 0.95 | 0.00% | 0.62 | 0.42 | |
CT vs CC | 1.52 (0.76–3.03) | 21.4 | <0.01 | 81.5% | 0.62 | 0.54 | |
TT vs CT+CC | 2.44 (1.42–4.21) | 1.07 | 0.90 | 0.00% | 0.62 | 0.81 | |
CT+TT vs CC | 1.23 (0.63–2.43) | 22.8 | <0.01 | 82.1% | 0.14 | 0.14 | |
European | T vs C | 1.33 (1.02–1.75) | 8.76 | 0.07 | 54.5% | 0.22 | 0.07 |
TT vs CT | 1.06(0.69–1.64) | 5.60 | 0.23 | 29.3% | 0.46 | 0.32 | |
TT vs CC | 1.72 (0.85–3.50) | 9.06 | 0.06 | 55.8% | 0.80 | 0.82 | |
CT vs CC | 1.64 (0.97–2.78) | 26.2 | <0.01 | 84.8% | 0.08 | 0.10 | |
TT vs CT+CC | 1.12 (0.38–3.85) | 4.67 | 0.458 | 0.00% | 1.00 | 0.53 | |
CT+TT vs CC | 1.82 (0.99–3.33) | 10.6 | 0.03 | 26.1% | 0.80 | 0.98 | |
A1298C | |||||||
Overall | C vs A | 0.91 (0.71–1.17) | 6.08 | 0.05 | 67.1% | 0.60 | 0.57 |
CC vs AA | 0.68 (0.30–1.54) | 0.22 | 0.90 | 0.00% | 0.60 | 0.94 | |
CC vs AC | 0.64 (0.35–1.19) | 0.73 | 0.70 | 0.00% | 0.12 | 0.15 | |
AC vs CC | 1.06 (0.74–1.51) | 6.91 | 0.03 | 71.0% | 0.60 | 0.79 | |
CC vs AC+AA | 0.66 (0.27–1.58) | 0.05 | 0.97 | 0.00% | 0.60 | 0.67 | |
CC+AC vs AA | 1.22 (0.65–2.26) | 4.70 | <0.10 | 81.7% | 0.12 | 0.78 |